About the JI
Established in 2010, the Joint Institute (JI) for Translational and Clinical Research is a partnership between Michigan Medicine and Peking University Health Science Center, in Beijing, to support meaningful health research collaboration on projects of mutual interest to both populations. To date, the JI has funded about 50 individual projects that span many disciplines. At the outset, projects in cardiovascular, renal, pulmonary, and gastrointestinal/liver medicine were prioritized. Over the years, other disciplines have been added. Most recently, JI leaders decided to prioritize research in the areas of cancer treatment and precision health.
JI-funded research has produced 62 publications to date, research which has appeared in leading academic medical journals including Academic Medicine, PLoS ONE, Gastroenterology, and many others. Institutional investments made through the JI are intended to seed pilot projects that can ultimately garner extramural funding. To date, nine JI teams have received $17 million in extramural funding for research as a result of their collaborations.